Abstract
Statins inhibit cholesterol synthesis but may also up-regulate cholesterol absorption. Studies evaluating markers of cholesterol metabolism suggest that cholesterol-lowering treatment efficacy may be the greatest with maximal inhibition of synthesis and limited compensatory increases in absorption. Ezetimibe is a selective cholesterol absorption inhibitor that also increases markers of cholesterol synthesis. Co-administration of ezetimibe with statins produces complementary effects and significantly greater reductions in LDL-C lowering than either drug alone.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
